Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors

This article provides billing and coding instructions for reporting Next-Generation Sequencing (NGS) for solid tumors under MolDX and complements LCD L38067. Claims must include the appropriate CPT and ICD-10-CM codes, report 1 unit of service, and include the correct DEX Z-Code adjacent to the CPT in the specified Part A/Part B claim fields (with no additional characters on SV101-7); follow related article A57910 for multiple-gene testing.

"Next-Generation Sequencing (NGS) for solid tumors billed under MolDX must be reported using the billing/coding elements specified in this article and in the referenced LCD L38067."

Sign up to see full coverage criteria, indications, and limitations.